INSIGHT-U.S. jockeys with China over GMO crop issues

Oct 31 (Reuters) - With U.S. approval for Dow AgroSciences' package of chemicals and new genetically engineered crops now in hand, the Dow Chemical Co unit faces a major obstacle to a $1 billion market opportunity: Chinese import barriers.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.